A detailed history of Skaana Management L.P. transactions in Ginkgo Bioworks Holdings, Inc. stock. As of the latest transaction made, Skaana Management L.P. holds 900 shares of DNA stock, worth $306. This represents 0.0% of its overall portfolio holdings.

Number of Shares
900
Previous 143,800 99.37%
Holding current value
$306
Previous $243,000 99.59%
% of portfolio
0.0%
Previous 0.16%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022

BUY
$2.2 - $4.2 $41,800 - $79,800
19,000 New
19,000 $45,000

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $438M
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Skaana Management L.P. Portfolio

Follow Skaana Management L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Skaana Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Skaana Management L.P. with notifications on news.